Hubert Schrezenmeier - Institut für klinische Transfusionsmedizin und Immungenetik Ulm, Universität Ulm

基本信息

浏览量：40

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 789 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Immunotherapeutic Potential of Mutated NPM1 for the Treatment of Acute Myeloid Leukemia

Jochen Greiner,Eithar Mohamed, Daniel M Fletcher,Patrick J Schuler,Hubert Schrezenmeier,Marlies Götz,Barbara-Ann Guinn

Cancersno. 20 (2024)

引用0浏览0WOS引用

Danicopan As Add-on Therapy to Ravulizumab or Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Long-Term Patient-Reported Outcomes from the Phase 3 ALPHA Trial

Caroline Piatek,Jong Wook Lee,Morag Griffin,Jun-Ichi Nishimura,Christopher Patriquin,Hubert Schrezenmeier,Wilma Barcellini,Jamile Shammo,Anna Gaya, Mohammed Mahdi, Peng Liu,Karl-Johan Myren,Andrew Messali,Flore Sicre de Fontbrune,Jens Panse,Austin G. Kulasekararaj

BLOOD (2024): 2693-2694

引用0浏览0引用

The Complement Model Disease Paroxysmal Nocturnal Hemoglobinuria

Christoph Q Schmidt,Britta Höchsmann,Hubert Schrezenmeier

European journal of immunologyno. 11 (2024): e2350817-e2350817

引用0浏览0WOS引用

Komplementinhibitoren in der Therapie der PNH: neue Substanzen - neue Optionen

Hubert Schrezenmeier,Sixten Körper,Astrid Marx-Hofmann

InFo Hämatologie + Onkologieno. 4 (2024): 20-24

引用0浏览0引用

Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (car) T Cell Treatment for Relapsed/Refractory Multiple Myeloma

Janine Kirchberg,Luise Fischer,Patrick Born, Franziska Brunner, Charlotte Morgner,Daniel Fuerst,Simone Heyn,Enrica Bach,Mandy Brueckner,Madlen Jentzsch,Song-Yau Wang,Sebastian Boettcher,Georg-Nikolaus Franke,Hubert Schrezenmeier,Uwe Platzbecker,Maximilian Merz,Vladan Vucinic

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2024）

引用0浏览0WOS引用

Monotherapy Treatment with Zaltenibart (OMS906), an Alternative Pathway Masp-3 Inhibitor, Improved Key Hematologic Parameters in Patients with PNH with a Suboptimal Response to Ravulizumab: Interim Results from a Phase 2 Proof-of-Concept Study

Morag Griffin,Richard J. Kelly, Mathilde Gavillet, Petra Muus,Britta Hoechsmann,W. Jason Cummings, John Efthimiou,William Pullman,Hubert Schrezenmeier,Jens Panse

Bloodno. Supplement 1 (2024): 4072-4072

引用0浏览0引用

Classical Haematology: Dynamic Development at the Interface of Transfusion Medicine and Haematology

Hubert Schrezenmeier

Transfusion medicine and hemotherapy offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologieno. 5 (2024): 289-291

引用0浏览0WOS引用

Outcomes of Haploidentical Transplants with PT-CY Vs 10/10 MUD Transplants with ATG in Germany

Aysenur Arslan, Svenja Labuhn,Elisa Sala,Mark Ringhoffer,Johannes Schetelig,Thomas Schroeder,Gesine Bug,Georg-Nikolaus Franke,Matthias Stelljes,Peter Dreger,Robert Zeiser,Daniel Teschner,Wolfgang Bethge,Matthias Eder,Matthias Edinger,Elisa Maria Amann,Christine Neuchel, Amelie Schmid-Moeglich, Sandra Schmeller,Jan Beyersmann,Hubert Schrezenmeier,Joannis Mytilineos,Nicolaus Kroeger,Daniel Fuerst

BLOOD ADVANCES（2024）

引用0浏览0WOS引用

Triple-fusion Protein (trifu): A Potent, Targeted, Enzyme-Like Inhibitor of All Three Complement Activation Pathways

Sophia J. Sonnentag,Arthur Dopler, Katharina Kleiner,Brijesh K. Garg,Marco Mannes, Nadja Spaeth, Amira Akilah,Britta Hoechsmann,Hubert Schrezenmeier,Markus Anliker, Ruby Boyanapalli,Markus Huber-Lang,Christoph Q. Schmidt

JOURNAL OF BIOLOGICAL CHEMISTRYno. 4 (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn